京新药业 (002020)

ZHEJIANG JINGXIN PHARMACEUTICAL Co., Ltd.

ASZ

Tags

CSI Share Buyback IndexGeneric DrugsInnovative DrugsPharmaceutical ManufacturingEmployee Stock OwnershipBuyback PlansNew Social Security Fund HoldingsHigh-Performing StocksHepatitis ConceptMargin Trading and Securities LendingSME 300 Index

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 86102.91
  • Circulating A-Shares(W): 72396.83
  • Earnings Per Share(RMB): 0.7000
  • Net Assets Per Share(RMB): 6.5635
  • Operating Revenue(W RMB): 304819.21
  • Total Profit(W RMB): 66491.61
  • Net Profit Attributable to Parent(W RMB): 57561.18
  • Net Profit Growth Rate(%): 0.10
  • Weighted Return on Equity(%): 10.1000
  • Operating Cash Flow Per Share(RMB): 0.7150
  • Undistributed Profit Per Share(RMB): 3.7027
  • Capital Reserve Per Share(RMB): 2.0016

2. Main Business

The main business covers:

  • Research, production, and sales of chemical preparations
  • Research, production, and sales of traditional Chinese medicine
  • Research, production, and sales of biological preparations
  • Research, production, and sales of chemical APIs
  • Research, production, and sales of medical devices

3. Company Basic Information

  • Company Name: Zhejiang Jingxin Pharmaceutical Co., Ltd.
  • Listing Date: 2004-07-15
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 800, Xinchang Avenue East, Yulin Street, Xinchang County, Zhejiang Province
  • Website: www.jingxinpharm.com
  • Company Profile: The company was established on September 29, 2001, with the approval of the Zhejiang Provincial Government Enterprise Listing Leading Group (Zhe Shang Shi [2001] No. 80). It was transformed from Zhejiang Xinchang Jingxin Pharmaceutical Co., Ltd. into a joint stock company. The company completed the industrial and commercial registration change procedures at the Zhejiang Provincial Administration for Industry and Commerce on October 25, 2001.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Jingxin Holding Group Co., Ltd. General Legal Person 13496.64 18.64
2 Shanghai International Group Asset Management Co., Ltd. General Legal Person 1230.99 1.70
3 National Social Security Fund Portfolio 110 Social Security Fund 772.75 1.07
4 Hong Kong Securities Clearing Company Ltd. Northbound Capital 745.88 1.03
5 E Fund Tahe Growth Equity Pension Product - Industrial and Commercial Bank of China Limited Asset Management Plan 664.30 0.92
6 China Merchants Prosperity Preferred Equity Securities Investment Fund Class A Fund 195.61 0.27
7 China Merchants Pioneer Securities Investment Fund Fund 159.15 0.22
8 Xinao Premium Life Mixed Securities Investment Fund Class A Fund 145.80 0.20
9 Tianhong Healthcare Mixed Securities Investment Fund Class A Fund 128.33 0.18
10 Hongtu Innovation Enhanced Return Bond Securities Investment Fund Class A Fund 105.04 0.15

5. Concept Sectors

  • Generic Drugs
  • Hepatitis Concept
  • Innovative Drugs
  • Margin Trading & Securities Lending
  • High-Performance Stocks
  • Share Buyback Plan
  • Employee Stock Ownership
  • New Social Security Fund Holdings
  • SME 300 Index
  • CSI Buyback Index

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information